Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Arterial Infusion Chemotherapy”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT04962958
What this trial is testing

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
CarcinomaCarcinoma, HepatocellularLiver Neoplasms+6 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Testing effectiveness (Phase 2)UnknownNCT05511051
What this trial is testing

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Testing effectiveness (Phase 2)WithdrawnNCT02345746
What this trial is testing

Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis

Who this might be right for
Metastatic Colorectal Cancer
Western Regional Medical Center
Testing effectiveness (Phase 2)UnknownNCT02987699
What this trial is testing

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914
What this trial is testing

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis
Tianjin Medical University Cancer Institute and Hospital 28
Not applicableStudy completedNCT05468593
What this trial is testing

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Who this might be right for
Colorectal Liver MetastasesColorectal Cancer
Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Not applicableUnknownNCT03591705
What this trial is testing

TACE-HAIC vs. HAIC for Potentially Resectable HCC

Who this might be right for
Potentially ResectionHepatocellular Carcinoma
Sun Yat-sen University 240
Testing effectiveness (Phase 2)Study completedNCT00149396
What this trial is testing

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver Neoplasms
MediGene 32
Testing effectiveness (Phase 2)Study completedNCT03693807
What this trial is testing

The Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Who this might be right for
Colorectal CancerCholangiocarcinoma
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07636798
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05400902
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Binkui Li 17
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Next Page